Penumbra (PEN) Other Non-Current Assets (2014 - 2026)
Penumbra (PEN) posted quarterly Other Non-Current Assets of $40.7 million for Q2 2026, up 0.75% year-over-year from $40.4 million in Q2 2025, and down 0.71% quarter-over-quarter from $41.0 million in Q1 2026.
Penumbra (PEN) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Other Non-Current Assets for 13 consecutive years, with $40.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Assets rose 0.75% year-over-year to $40.7 million; the TTM figure through Jun 2026 stood at $40.7 million (up 0.75% YoY), while the FY2025 annual figure was $40.7 million, down 0.54% from the prior year.
- Other Non-Current Assets retreated to $40.7 million in Q2 2026 per PEN's latest filing, from $41.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $43.7 million in Q1 2025 and bottomed at $10.5 million in Q2 2023.
- Historically, Other Non-Current Assets has averaged $28.6 million across 5 years, with a median of $36.2 million in 2024.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets decreased 24.84% — and 2024, when it jumped 266.84%.
- Penumbra's Other Non-Current Assets stood at $12.8 million in 2022, then jumped by 102.3% to $25.9 million in 2023, then soared by 58.19% to $40.9 million in 2024, then decreased by 0.54% to $40.7 million in 2025, then dropped by 0.06% to $40.7 million in 2026.
- Business Quant data shows PEN's Other Non-Current Assets at $40.7 million in Q2 2026, $41.0 million in Q1 2026, and $40.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | 40.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.69 Mn |
| Mar 31, 2026 | 40.98 Mn |
| Dec 31, 2025 | 40.72 Mn |
| Sep 30, 2025 | 40.02 Mn |
| Jun 30, 2025 | 40.39 Mn |
| Mar 31, 2025 | 43.73 Mn |
| Dec 31, 2024 | 40.94 Mn |
| Sep 30, 2024 | 38.51 Mn |
| Jun 30, 2024 | 38.52 Mn |
| Mar 31, 2024 | 33.81 Mn |
| Dec 31, 2023 | 25.88 Mn |
| Sep 30, 2023 | 14.74 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 11.17 Mn |
| Dec 31, 2022 | 12.79 Mn |
| Sep 30, 2022 | 13.48 Mn |
| Jun 30, 2022 | 13.97 Mn |
| Mar 31, 2022 | 13.69 Mn |
| Dec 31, 2021 | 12.99 Mn |
| Sep 30, 2021 | 11.37 Mn |